Tisagenlecleucel In Primary CNS Lymphoma

Clinical trial NCT04134117 · COMPLETED

Trial details

NCT number: NCT04134117
Sponsor: Matthew J. Frigault, M.D.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary CNS Lymphoma Refractory Primary CNS Lymphoma Relapsed Primary CNS Lymphoma

Start date: 2019-01-01
Primary completion: 2022-04-14
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.